1. Home
  2. RPGL vs OSRHW Comparison

RPGL vs OSRHW Comparison

Compare RPGL & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPGL
  • OSRHW
  • Stock Information
  • Founded
  • RPGL 2015
  • OSRHW N/A
  • Country
  • RPGL Singapore
  • OSRHW United States
  • Employees
  • RPGL N/A
  • OSRHW 21
  • Industry
  • RPGL Computer Software: Prepackaged Software
  • OSRHW
  • Sector
  • RPGL Technology
  • OSRHW
  • Exchange
  • RPGL Nasdaq
  • OSRHW Nasdaq
  • Market Cap
  • RPGL N/A
  • OSRHW N/A
  • IPO Year
  • RPGL 2025
  • OSRHW 2023
  • Fundamental
  • Price
  • RPGL $1.12
  • OSRHW $0.05
  • Analyst Decision
  • RPGL
  • OSRHW
  • Analyst Count
  • RPGL 0
  • OSRHW 0
  • Target Price
  • RPGL N/A
  • OSRHW N/A
  • AVG Volume (30 Days)
  • RPGL 2.3M
  • OSRHW N/A
  • Earning Date
  • RPGL 11-16-2025
  • OSRHW N/A
  • Dividend Yield
  • RPGL N/A
  • OSRHW N/A
  • EPS Growth
  • RPGL N/A
  • OSRHW N/A
  • EPS
  • RPGL N/A
  • OSRHW N/A
  • Revenue
  • RPGL $396,737.00
  • OSRHW N/A
  • Revenue This Year
  • RPGL N/A
  • OSRHW N/A
  • Revenue Next Year
  • RPGL N/A
  • OSRHW N/A
  • P/E Ratio
  • RPGL N/A
  • OSRHW N/A
  • Revenue Growth
  • RPGL N/A
  • OSRHW N/A
  • 52 Week Low
  • RPGL $1.02
  • OSRHW N/A
  • 52 Week High
  • RPGL $5.19
  • OSRHW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RPGL N/A
  • OSRHW N/A
  • Support Level
  • RPGL N/A
  • OSRHW N/A
  • Resistance Level
  • RPGL N/A
  • OSRHW N/A
  • Average True Range (ATR)
  • RPGL 0.00
  • OSRHW 0.00
  • MACD
  • RPGL 0.00
  • OSRHW 0.00
  • Stochastic Oscillator
  • RPGL 0.00
  • OSRHW 0.00

About OSRHW OSR Holdings Inc. Warrant

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: